Literature DB >> 5013063

On the effect of amantadine on monoamines and their metabolites in the brain and cerebrospinal fluid.

U K Rinne, V Sonninen, M Hyyppä.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5013063     DOI： 10.1007/BF01928264

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  18 in total

1.  The effect of amantadine on the uptake of dopamine and noradrenaline by rat brain homogenates.

Authors:  E A Fletcher; P H Redfern
Journal:  J Pharm Pharmacol       Date:  1970-12       Impact factor: 3.765

2.  On the mode of action of amantadine.

Authors:  U Stromberg; T H Svensson; B Waldeck
Journal:  J Pharm Pharmacol       Date:  1970-12       Impact factor: 3.765

3.  Amantadine in parkinsonism.

Authors:  K R Hunter; G M Stern; D R Laurence; P Armitage
Journal:  Lancet       Date:  1970-05-30       Impact factor: 79.321

4.  Amantadine in Parkinson's disease.

Authors:  P Millac; I Hasan; M L Espir; D G Slyfield
Journal:  Lancet       Date:  1970-02-28       Impact factor: 79.321

5.  Controlled trial of amantadine hydrochloride in Parkinson's disease.

Authors:  J D Parkes; D M Calver; K J Zilkha; R P Knill-Jones
Journal:  Lancet       Date:  1970-02-07       Impact factor: 79.321

6.  Amantadine hydrochloride in the treatment of Parkinson's disease.

Authors:  B S Gilligan; J Veale; J Wodak
Journal:  Med J Aust       Date:  1970-10-03       Impact factor: 7.738

Review 7.  Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.

Authors:  A T Moir; G W Ashcroft; T B Crawford; D Eccleston; H C Guldberg
Journal:  Brain       Date:  1970       Impact factor: 13.501

8.  Amantadine in the treatment of Parkinson's disease.

Authors:  R S Schwab; A C England; D C Poskanzer; R R Young
Journal:  JAMA       Date:  1969-05-19       Impact factor: 56.272

9.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

10.  Amantadine versus L-2 dopa and amatadine plus L-dopa.

Authors:  C Fieschi; M Nardini; M Casacchia; M E Tedone; M Reitano; E Robotti
Journal:  Lancet       Date:  1970-07-18       Impact factor: 79.321
View more
  3 in total

1.  On the effect of amantadine on ATP content and ATPase activity in brain and blood of rats.

Authors:  V A Velkov
Journal:  Experientia       Date:  1974-04-15

2.  Amantadine actions on acetylcholine and GABA in striatum and substantia nigra of rat in relation to behavioral changes.

Authors:  I J Bak; R Hassler; J S Kim; K Kataoka
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

Review 3.  Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.

Authors:  Wojciech Danysz; Andrzej Dekundy; Astrid Scheschonka; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2021-02-23       Impact factor: 3.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.